Upfront Nephrectomy for the Treatment of Wilms Tumor: Outcomes and Predictors of Complications

Abstract

Wilms tumor (WT) is the most common kidney tumor in children. Upfront nephrectomy and preoperative chemotherapy, the two different treatment strategies, have not shown considerable differences in the outcomes. Research focus has turned into decreasing the incidences of posttreatment morbidity. The aim of this study is to determine the existence of prognostic factors and the predictors of surgical complications with upfront surgery following COG protocol. Medical records of patients with WT treated with upfront surgery between 2003 and 2013 were retrospectively reviewed focusing on surgical aspects and complications. Forty-five patients were identified. The mean age at diagnosis was 3.8 years (2–154 months). Thirteen of them had stage I disease (28.9%), 12 stage II (26.7%), 15 stage III (33.3%), and 5 stage IV (11.1%). Mean follow-up was 4.5 years (2–132 months). The 4-year overall survival (OS) and event-free survival (EFS) was 100 and 91.1%, respectively. There were 4 cases of disease progression (3 lung disease and 1 locoregional relapse). We had two cases of intraoperative tumor rupture (4.4%), one partial colectomy, and a distal pancreatectomy. The most common complication was associated with blood transfusion (44.4%). The existence of anaplasia was a risk factor for progression (p = 0.01). Clinical stage and tumor size positively correlated with transfusion (p = 0.001); this relationship was not observed for other complications. Clinical stage and tumor size are predictors of surgical complications and anaplasia for progression. Standardized surgical complications scales such as Clavien–Dindo should be used to properly compare surgical outcomes between different treatment approaches.

Keywords

Wilms tumor - treatment - surgery - complications

Note

This research complies with ethical standards; waiver of authorization was obtained from our institutional review board, and informed consent of patients was also obtained.

• References

• 1 Ko EY, Ritchey ML. Current management of Wilms' tumor in children. J Pediatr Urol 2009; 5 (01) 56-65
• 2 Green DM, Breslow NE, Beckwith JB. , et al. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 1998; 16 (01) 237-245
• 3 Tournade MF, Com-Nougué C, de Kraker J. , et al; International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 2001; 19 (02) 488-500
• 4 Ritchey ML, Shamberger RC, Haase G, Horwitz J, Bergemann T, Breslow NE. Surgical complications after primary nephrectomy for Wilms' tumor: report from the National Wilms' Tumor Study Group. J Am Coll Surg 2001; 192 (01) 63-68 , quiz 146
• 5 Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240 (02) 205-213
• 6 Fuchs J, Kienecker K, Furtwängler R. , et al. Surgical aspects in the treatment of patients with unilateral Wilms tumor: a report from the SIOP 93-01/German Society of Pediatric Oncology and Hematology. Ann Surg 2009; 249 (04) 666-671
• 7 Powis M, Messahel B, Hobson R, Gornall P, Walker J, Pritchard-Jones K. Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms' tumour: findings from the 1991-2001 United Kingdom Children's Cancer Study Group UKW3 Trial. J Pediatr Surg 2013; 48 (11) 2181-2186
• 8 Breslow N, Sharples K, Beckwith JB. , et al. Prognostic factors in nonmetastatic, favorable histology Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer 1991; 68 (11) 2345-2353
• 9 Lemerle J, Voute PA, Tournade MF. , et al. Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (S.I.O.P.). Cancer 1976; 38 (02) 647-654
• 10 Mitchell C, Pritchard-Jones K, Shannon R. , et al; United Kingdom Cancer Study Group. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group. Eur J Cancer 2006; 42 (15) 2554-2562
• 11 Ritchey ML, Godzinski J, Shamberger RC, Haase G, deKraker J, Graf N. Surgical complications following nephrectomy for Wilms tumor: prospective study from NWTSG and SIOP. Presented at the American Academy of Pediatrics Annual Meeting; 2004
• 12 D'Angio GJ. Pre- or postoperative therapy for Wilms' tumor?. J Clin Oncol 2008; 26 (25) 4055-4057
• 13 Stehr M, Deilmann K, Haas RJ, Dietz H-G. Surgical complications in the treatment of Wilms' tumor. Eur J Pediatr Surg 2005; 15 (06) 414-419
• 14 Zuppan CW, Beckwith JB, Luckey DW. Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study Pathology Center. Hum Pathol 1988; 19 (10) 1199-1209
• 15 D'Angio GJ, Evans A, Breslow N. , et al. The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study. Cancer 1981; 47 (09) 2302-2311
• 16 Breslow N, Churchill G, Beckwith JB. , et al. Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis--results of the second National Wilms' Tumor Study. J Clin Oncol 1985; 3 (04) 521-531